rs61750081
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM5PP2PP3_ModeratePP5_Very_Strong
The ENST00000261405.10(VWF):āc.4247T>Cā(p.Ile1416Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1416N) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000261405.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.4247T>C | p.Ile1416Thr | missense_variant | 28/52 | ENST00000261405.10 | NP_000543.3 | |
VWF | XM_047429501.1 | c.4247T>C | p.Ile1416Thr | missense_variant | 28/52 | XP_047285457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.4247T>C | p.Ile1416Thr | missense_variant | 28/52 | 1 | NM_000552.5 | ENSP00000261405 | P1 | |
VWF | ENST00000538635.5 | n.421-25237T>C | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251152Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135736
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461672Hom.: 0 Cov.: 99 AF XY: 0.00000413 AC XY: 3AN XY: 727146
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jul 29, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 16, 2024 | PP1_strong, PP5, PM2, PS3, PS4_moderate - |
Hereditary von Willebrand disease Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 14, 2022 | Variant summary: VWF c.4247T>C (p.Ile1416Thr) results in a non-conservative amino acid change located in the type A1 domain (IPR002035), affecting the binding site for platelet glycoprotein Ib (amino acids 1277 -1453; UniProt) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251152 control chromosomes (gnomAD). c.4247T>C has been reported in the literature in multiple individuals in a family, who were affected with Von Willebrand Disease (McKinnon_2012). These data indicate that the variant is very likely to be associated with disease. This publication also reported experimental evidence evaluating an impact on protein function, and demonstrated significantly reduced glycoprotein Ib binding (McKinnon_2012). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 , and both of them classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 02, 2020 | The VWF c.4247T>C (p.Ile1416Thr) variant is a missense variant that has been reported in two studies, in which it is found in a heterozygous state in 11 individuals from two families with von Willebrand disease type 2 (McKinnon et al. 2012; Starke et al. 2013). The large family reported in McKinnon et al. (2012) includes nine affected individuals across three generations. The p.Ile1416Thr variant was absent from nine control subjects. It is reported at a frequency of 0.000009 in the European (non-Finnish) population of the Genome Aggregation Database though this is based on one allele in a region of good sequence coverage so the variant is presumed to be rare. The variant is in the A1 domain of the protein, and transient transfection in HEK293T cells reduced expression by ~40% and significantly reduced GPIb-a (McKinnon et al. 2012). Another pathogenic variant, p.Ile1416Asn, is located at the same amino acid residue (McKinnon et al. 2012). Based on the collective evidence and application of the ACMG criteria, the p.Ile1416Thr variant is classified as pathogenic for von Willebrand disease. - |
von Willebrand disease type 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jul 19, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at